Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy
Phase 3
Completed
- Conditions
- Gynecological Laparoscopy
- Interventions
- Registration Number
- NCT00927979
- Lead Sponsor
- Carmel Medical Center
- Brief Summary
In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecologic laparoscopic surgery. This is a second steady with protocol of general anesthesia used of Remifentanil.
- Detailed Description
Outcome Measures :
* VAS score
* Use of analgesics during operation and postoperative period
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
- Elective gynecological laparoscopic surgery including unilateral or bilateral salpingo-oophorectomy or ovarian cystectomy
- Patient not participating in other medical study at present or during the last 30 days
- Patient is capable of reading, understanding and signing on an informed consent
- Age 18 years and above
- ASA physical status grade 1-2
Read More
Exclusion Criteria
- Allergy to ropivacaine or other local anesthetics or other medications listed in the protocol
- Acute pelvic inflammatory disease
- Coumadin or aspirin treatment
- Significant arrythmias
- Analgesic treatment for chronic pain
- BMI>35
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ropivacaine 10 mLRopivacaine 1% - Ropivacaine 10 mL Ropivacaine 1% - Water for injection Water for injection -
- Primary Outcome Measures
Name Time Method Visual Analog Score (VAS) 24 hours
- Secondary Outcome Measures
Name Time Method Use of Analgesics 24 hours